Comments on "sensitivity of Estimands in Clinical Trials with Imperfect Compliance" by Chen and Heitjan
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Chen and Heitjan (Sensitivity of estimands in clinical trials with imperfect compliance. Int J Biostat. 2023) used linear extrapolation to estimate the population average causal effect (PACE) from the complier average causal effect (CACE) in multiple randomized trials with all-or-none compliance. For extrapolating from CACE to PACE in this setting and in the paired availability design involving different availabilities of treatment among before-and-after studies, we recommend the sensitivity analysis in Baker and Lindeman (J Causal Inference, 2013) because it is not restricted to a linear model, as it involves various random effect and trend models.
References
1.
Chen H, Heitjan D
. Sensitivity of estimands in clinical trials with imperfect compliance. Int J Biostat. 2023; 20(1):57-67.
DOI: 10.1515/ijb-2022-0105.
View
2.
Sheng E, Li W, Zhou X
. Estimating causal effects of treatment in RCTs with provider and subject noncompliance. Stat Med. 2018; 38(5):738-750.
DOI: 10.1002/sim.8012.
View
3.
Swanson S, Hernan M, Miller M, Robins J, Richardson T
. Partial Identification of the Average Treatment Effect Using Instrumental Variables: Review of Methods for Binary Instruments, Treatments, and Outcomes. J Am Stat Assoc. 2019; 113(522):933-947.
PMC: 6752717.
DOI: 10.1080/01621459.2018.1434530.
View
4.
Lee K, Lorch S, Small D
. Sensitivity analyses for average treatment effects when outcome is censored by death in instrumental variable models. Stat Med. 2019; 38(13):2303-2316.
DOI: 10.1002/sim.8117.
View
5.
Frangakis C, Rubin D
. Principal stratification in causal inference. Biometrics. 2002; 58(1):21-9.
PMC: 4137767.
DOI: 10.1111/j.0006-341x.2002.00021.x.
View